SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-287465
Filing Date
2019-11-07
Accepted
2019-11-07 17:20:04
Documents
8
Period of Report
2019-11-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d790346d8k.htm 8-K 31236
2 EX-1.1 d790346dex11.htm EX-1.1 376973
3 EX-3.1 d790346dex31.htm EX-3.1 56733
4 EX-4.1 d790346dex41.htm EX-4.1 64810
5 EX-4.2 d790346dex42.htm EX-4.2 60512
6 EX-5.1 d790346dex51.htm EX-5.1 13108
7 EX-99.1 d790346dex991.htm EX-99.1 9599
8 GRAPHIC g790346g1107215550110.jpg GRAPHIC 6588
  Complete submission text file 0001193125-19-287465.txt   623453
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
Sierra Oncology, Inc. (Filer) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37490 | Film No.: 191201365
SIC: 2834 Pharmaceutical Preparations